Journal of Vaccines & Vaccination

Plant expression platforms for vaccine production

10^th Euro Global Summit and Expo on Vaccines & Vaccination

June 16-18, 2016 Rome, Italy

Kathleen Hefferon

Cornell University, USA

Scientific Tracks Abstracts: J Vaccines Vaccin

Abstract:

Plant made biologics have elicited much attention over recent years for their potential in assisting those in developing countries who have poor access to modern medicine. Additional applications such as the stockpiling of vaccines against pandemic infectious diseases or potential biological warfare agents are also under investigation. Plant virus expression vectors represent a technology that enables high levels of pharmaceutical proteins to be produced in a very short period of time. Recent advances in research and development have brought about the generation of superior virus expression systems which can be readily delivered to the host plant in a manner that is both efficient and cost effective. The following presentation describes recent innovations in plant virus expression systems and their uses for producing biologics from plants.

Biography :

Kathleen Hefferon has received her PhD from the Department of Medical Biophysics, University of Toronto and continued her Postdoctoral studies at Cornell University. She has worked as Faculty at the Division of Nutritional Sciences at Cornell and has written two books on biopharmaceuticals in plants. She teaches and conducts research at both the University of Toronto and Cornell University. She has 4 patents, edited 6 books and has multiple research publications.

Email: klh22@cornell.edu